VEGFA and neoplasm: This alternative mechanism of angiogenesis utilized by tumor cells may be VEGF-independent and therefore could escape from antiangiogenic therapy targeting VEGF, which partially explains the disappointing results of traditional angiogenesis inhibitors [13–15].